Goldman Sachs’s Vanda Pharmaceuticals VNDA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$1.92M Sell
406,731
-287,121
-41% -$1.36M ﹤0.01% 3443
2025
Q1
$3.18M Sell
693,852
-93,965
-12% -$431K ﹤0.01% 3058
2024
Q4
$3.77M Buy
787,817
+27,459
+4% +$132K ﹤0.01% 3070
2024
Q3
$3.57M Buy
760,358
+403,812
+113% +$1.89M ﹤0.01% 2989
2024
Q2
$2.01M Sell
356,546
-148,839
-29% -$841K ﹤0.01% 3182
2024
Q1
$2.08M Buy
505,385
+44,172
+10% +$182K ﹤0.01% 3183
2023
Q4
$1.95M Sell
461,213
-1,211,363
-72% -$5.11M ﹤0.01% 3224
2023
Q3
$7.23M Sell
1,672,576
-430,915
-20% -$1.86M ﹤0.01% 2212
2023
Q2
$13.9M Buy
2,103,491
+452,554
+27% +$2.98M ﹤0.01% 1803
2023
Q1
$11.2M Buy
1,650,937
+159,703
+11% +$1.08M ﹤0.01% 1926
2022
Q4
$11M Sell
1,491,234
-213,680
-13% -$1.58M ﹤0.01% 2060
2022
Q3
$16.8M Sell
1,704,914
-127,767
-7% -$1.26M ﹤0.01% 1727
2022
Q2
$20M Sell
1,832,681
-47,819
-3% -$521K 0.01% 1612
2022
Q1
$21.3M Buy
1,880,500
+179,244
+11% +$2.03M ﹤0.01% 1680
2021
Q4
$26.7M Buy
1,701,256
+885,431
+109% +$13.9M 0.01% 1558
2021
Q3
$14M Buy
815,825
+157,413
+24% +$2.7M ﹤0.01% 1999
2021
Q2
$14.2M Buy
658,412
+112,063
+21% +$2.41M ﹤0.01% 1988
2021
Q1
$8.21M Sell
546,349
-259,988
-32% -$3.9M ﹤0.01% 2333
2020
Q4
$10.6M Buy
806,337
+9,247
+1% +$122K ﹤0.01% 2010
2020
Q3
$7.7M Buy
797,090
+277,706
+53% +$2.68M ﹤0.01% 2120
2020
Q2
$5.94M Sell
519,384
-115,163
-18% -$1.32M ﹤0.01% 2244
2020
Q1
$6.57M Sell
634,547
-36,839
-5% -$382K ﹤0.01% 2073
2019
Q4
$11M Sell
671,386
-307,731
-31% -$5.05M ﹤0.01% 1986
2019
Q3
$13M Buy
979,117
+325,430
+50% +$4.32M ﹤0.01% 1798
2019
Q2
$9.21M Sell
653,687
-177,048
-21% -$2.49M ﹤0.01% 1991
2019
Q1
$15.3M Buy
830,735
+169,200
+26% +$3.11M ﹤0.01% 1777
2018
Q4
$17.3M Buy
661,535
+73,456
+12% +$1.92M 0.01% 1613
2018
Q3
$13.5M Buy
588,079
+383,660
+188% +$8.81M ﹤0.01% 1877
2018
Q2
$3.89M Sell
204,419
-25,394
-11% -$484K ﹤0.01% 2532
2018
Q1
$3.87M Buy
229,813
+39,955
+21% +$673K ﹤0.01% 2492
2017
Q4
$2.89M Sell
189,858
-236,250
-55% -$3.59M ﹤0.01% 2628
2017
Q3
$7.63M Buy
426,108
+105,018
+33% +$1.88M ﹤0.01% 2127
2017
Q2
$5.23M Sell
321,090
-7,778
-2% -$127K ﹤0.01% 2254
2017
Q1
$4.6M Sell
328,868
-144,041
-30% -$2.02M ﹤0.01% 2243
2016
Q4
$7.54M Sell
472,909
-367,253
-44% -$5.86M ﹤0.01% 1959
2016
Q3
$14M Buy
840,162
+492,276
+142% +$8.19M ﹤0.01% 1665
2016
Q2
$3.89M Buy
347,886
+34,980
+11% +$391K ﹤0.01% 2269
2016
Q1
$2.62M Buy
312,906
+253,644
+428% +$2.12M ﹤0.01% 2383
2015
Q4
$552K Sell
59,262
-77,268
-57% -$720K ﹤0.01% 3196
2015
Q3
$1.54M Sell
136,530
-2,699,956
-95% -$30.5M ﹤0.01% 2684
2015
Q2
$36M Sell
2,836,486
-1,368,906
-33% -$17.4M 0.01% 1043
2015
Q1
$39.1M Buy
4,205,392
+4,026,749
+2,254% +$37.4M 0.01% 990
2014
Q4
$2.56M Sell
178,643
-550,305
-75% -$7.88M ﹤0.01% 2362
2014
Q3
$7.57M Buy
728,948
+202,477
+38% +$2.1M ﹤0.01% 1746
2014
Q2
$8.52M Buy
526,471
+197,191
+60% +$3.19M ﹤0.01% 1695
2014
Q1
$5.35M Sell
329,280
-171,469
-34% -$2.79M ﹤0.01% 1937
2013
Q4
$6.21M Buy
500,749
+157,523
+46% +$1.95M ﹤0.01% 1844
2013
Q3
$3.76M Buy
343,226
+322,274
+1,538% +$3.53M ﹤0.01% 2095
2013
Q2
$169K Buy
+20,952
New +$169K ﹤0.01% 3685